Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial

被引：0
|
作者：
Matthias Uhl
Klaus Herfarth
Michael J Eble
Michael Pinkawa
Baukelien van Triest
Robin Kalisvaart
Damien C Weber
Raymond Miralbell
Danny Y Song
Theodore L DeWeese
机构：
[1] University of Heidelberg,Department of Radiation Oncology
[2] RWTH Aachen University,Department of Radiation Oncology
[3] NKI-AVL Nederlands Kanker Instituut - Antoni van Leeuwenhoek,Department of Radiation Oncology
[4] Geneva University Hospital,Department of Radiation Oncology
[5] Johns Hopkins University School of Medicine,Department of Radiation Oncology and Molecular Radiation Sciences
来源：
Radiation Oncology | / 9卷
关键词：
Prostate cancer; Radiotherapy; Rectal toxicity; Hydrogel; Spacer; IMRT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial
    Fink, C. A.
    Ristau, J.
    Buchele, C.
    Klueter, S.
    Liermann, J.
    Hoegen-Sassmannshausen, P.
    Sandrini, E.
    Lentz-Hommertgen, A.
    Baumann, L.
    Andratschke, N.
    Baumgartl, M.
    Li, M.
    Reiner, M.
    Corradini, S.
    Hoerner-Rieber, J. Ho
    Bonekamp, D.
    Schlemmer, H. -P.
    Belka, C.
    Guckenberger, M.
    Debus, J.
    Koerber, S. A.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [22] Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy
    Saadipoor, Afshin
    Razzaghdoust, Abolfazl
    Simforoosh, Nasser
    Mahdavi, Arash
    Bakhshandeh, Mohsen
    Moghadam, Maryam
    Abdollahi, Hamid
    Mofid, Bahram
    PHYTOTHERAPY RESEARCH, 2019, 33 (02) : 370 - 378
  • [23] Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study-The IPI Trial
    Habl, Gregor
    Uhl, Matthias
    Katayama, Sonja
    Kessel, Kerstin A.
    Hatiboglu, Gencay
    Hadaschik, Boris
    Edler, Lutz
    Tichy, Diana
    Ellerbrock, Malte
    Haberer, Thomas
    Wolf, Maja B.
    Schlemmer, Heinz-Peter
    Debus, Juergen
    Herfarth, Klaus
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (01): : 435 - 443
  • [24] Long-term Results of Hypofractionated Radiotherapy With Intra-prostatic Boosts in Men With Intermediate- and High-risk Prostate Cancer: A Phase II Trial
    Chatterjee, R.
    Chan, J.
    Mayles, H.
    Cicconi, S.
    Syndikus, I.
    CLINICAL ONCOLOGY, 2024, 36 (12) : e473 - e482
  • [25] De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial)
    Haderlein, Marlen
    von der Gruen, Jens
    Balermpas, Panagiotis
    Roedel, Claus
    Hautmann, Matthias G.
    Steger, Felix
    Bohr, Christopher
    Hehr, Thomas
    Stromberger, Carmen
    Budach, Volker
    Schymalla, Markus
    Engenhart-Cabillic, Rita
    Kocik, Lukas
    Geinitz, Hans
    Nestle, Ursula
    Klautke, Gunter
    Scherl, Claudia
    Gall, Christine
    Frey, Benjamin
    Schubert, Philipp
    Semrau, Sabine
    Ott, Oliver
    Kesting, Marco
    Iro, Heinrich
    Mueller, Sarina K.
    Fietkau, Rainer
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
    Ost, Piet
    Reynders, Dries
    Decaestecker, Karel
    Fonteyne, Valerie
    Lumen, Nicolaas
    De Bruycker, Aurelie
    Lambert, Bieke
    Delrue, Louke
    Bultijnck, Renee
    Claeys, Tom
    Goetghebeur, Els
    Villeirs, Geert
    De Man, Kathia
    Ameye, Filip
    Billiet, Ignace
    Joniau, Steven
    Vanhaverbeke, Friedl
    De Meerleer, Gert
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 446 - +
  • [27] Locally advanced prostate cancer - Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy
    Bruchovsky, Nicholas
    Klotz, Laurence
    Crook, Juanita
    Goldenberg, S. Larry
    CANCER, 2007, 109 (05) : 858 - 867
  • [28] Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: Mature prospective phase I/II study results
    Duchesne, Gillian Mary
    Williams, Scott Garrick
    Das, Ram
    Tai, Keen Hun
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 (02) : 128 - 134
  • [29] Ultrahypofractionated CyberKnife™ based stereotactic radiotherapy versus conventional radiotherapy in patients with prostate cancer - acute toxicity evaluation in two phase II prospective studies
    Glowacki, G.
    Majewski, W.
    Wojcieszek, P.
    Grabinska, K.
    Wozniak, G.
    Miszczyk, L.
    NEOPLASMA, 2017, 64 (04) : 599 - 604
  • [30] Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study
    Maluta, S.
    Dall'oglio, S.
    Romano, M.
    Marciai, N.
    Pioli, F.
    Giri, M. G.
    Benecchi, P. L.
    Comunale, L.
    Porcaro, A. B.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2007, 23 (05) : 451 - 456
12345